Lung cytokines and ARDS: Roger S. Mitchell lecture

Chest

Volumn 116, Issue SUPPL., 1999, Pages

  Martin, Thomas R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; PROCOLLAGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; CONFERENCE PAPER; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LUNG LAVAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE REPAIR;

EID: 0344654729     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_1.2S     Document Type: Conference Paper

References (73)

1. Pittet JF, Mackersie R, Martin TR, et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155:1187-1205
2. Martin TR. Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance. Nat Med 1997; 3:272-273
3. Nelson S, Bagby GJ, Bainton BG, et al. Compartmentalization of intra-alveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159:189-194
4. Tutor JD, Mason CM, Dobard E, et al. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149:1107-1111
5. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
6. Steinberg KP, Mitchell DR, Maunder RJ, et al. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148:556-561
7. Miller EJ, Nagao S, Griffith D, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
8. Pugin J, Ricou B, Steinberg KP, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β. Am J Respir Crit Care Med 1996; 153:1850-1856
9. Sylvester I, Yoshimura T, Sticherling M, et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 1992; 90:471-481
10. Kurdowska A, Miller EJ, Noble JM, et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 1996; 157:2699-2706
11. 2-macroglobulin. J Immunol 1997; 158:1930-1940
12. Bachofen A, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977; 116:589-615
13. Bachofen A, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982; 3:35-56
14. Tomashefski JF Jr, Davies P, Boggis L, et al. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983; 112:112-126
15. Boxer LA, Axtell R, Suchard S. The role of the neutrophil in inflammatory diseases of the lung. Blood Cells 1990; 16: 25-42
16. Repine JE, Beehler CJ. Neutrophils and the adult respiratory distress syndrome: two interlocking perspectives. Am Rev Respir Dis 1991; 144:251-252
17. Strieter RM, Standiford TJ, Huffnagle GB, et al. 'The good, the bad, and the ugly': the role of chemokines in models of human disease. J Immunol 1996; 156:3583-3586
18. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433
19. Pugin J, Heumann ID, Tomasz A, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1:509-516
20. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13:437-457
21. Pugin J, Shurer-Maly C-C, Leturcq D, et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90:2744-2748
22. Martin TR, Mathison JC, Tobias PS, et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipolysaccharide: implications for cytokine production in normal and injured lungs. J Clin Invest 1992; 90:2209-2219
23. Hasday JD, Dubin W, Mongovin S, et al. Bronchoalvelar macrophage CD14 expression: shift between the membrane-associated and soluble pools. Am J Physiol (Lung Cell Mol Physiol) 1997; 272:L925-L933
24. Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:937-944
25. Leturcq DJ, Moriarty AM, Talbott G, et al. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98:1533-1538
26. Schimke J, Mathison J, Morgiewicz J, et al. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin [in process citation], Proc Natl Acad Sci USA 1998; 95:13875-13880
27. Rolfe MW, Kunkel SL, Standiford TJ, et al. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 1991; 5:493-501
28. Rolfe MW, Kunkel SL, Standiford TJ, et al. Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am J Physiol (Lung Cell Mol Physiol) 1992; 263:L536-L545
29. Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 1990; 86:1945-1953
30. Standiford TJ, Kunkel SL, Phan SH, et al. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 1991; 266:9912-9918
31. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022
32. Hyers TM, Tricomi SM, Dettenmeier PA, et al. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am J Respir Crit Care Med 1991; 144:268-271
33. Vandenabeele P, Declercq W, Beyaert R, et al. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995; 5:392-399
34. Martin TR, Ruzinski JT, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 1998; 157: A679
35. Jacobs RF, Tabor DR, Burks AW, et al. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140:1686-1692
36. Goodman RB, Strieter RM, Steinberg KP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:602-611
37. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147
38. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705
39. Donnelly SC, Strieter RM, Kunkel S, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk groups. Lancet 1993; 341:643-647
40. Villard J, Dayer-Pastore F, Hamacher J, et al. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:1549-1554
41. Goodman RB, Strieter RM, Frevert CW, et al. Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages. Am J Physiol (Lung Cell Mol Physiol) 1998; 19:L87-L95
42. Martin TR, Goodman RB. The role of chemokines in the pathophysiology of the acute respiratory distress syndrome (ARDS). In: Hebert G, ed. Chemokines in disease. New York, NY: Humana Press, 1999; 81-110
43. Parsons PE, Fowler AA III, Hyers TM, et al. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:490-493
44. Kuschert GS, Hoogewerf AJ, Proudfoot AEI, et al. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 1998; 37:11193-11201
45. Papanicolaou DA, Wilder RL, Manolagas SC, et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128:127-137
46. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in humans: IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
47. Abraham E, Glauser MP, Butler T, et al. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: a randomized controlled multicenter trial. JAMA 1997; 277:1531-1538
48. Florentine DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-3822
49. Ramani M, Ollivier V, Khechai F, et al. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett 1993; 334 (No. 1, November): 114-116
50. Standiford TJ, Strieter RM, Lukacs NW, et al. Neutralization of IL-10 increases lethality in endotoxemia. J Immunol 1995; 155:2222-2229
51. Van Der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155:5397-5401
52. Greenberger MJ, Strieter RM, Kunkel SL, et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995; 155:722-729
53. Van Der Poll T, Marchant A, Keogh CV, et al. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000
54. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125:191-196
55. Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in the acute respiratory distress syndrome. Nat Med 1997; 3:320-323
56. Bucala R. MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 1996; 10:1607-1613
57. Martin TR, Donnelly SC, Steinberg KP, et al. Macrophage inhibitory factor (MIF) in the lungs of patients with acute respiratory distress syndrome (ARDS) [abstract]. Am J Respir Crit Care Med 1998; 157:A459
58. Matute-Bello G, Liles WC, Radella FR II, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 156:1969-1977
59. Matute-Bello G, Liles WC, Radella F, et al. Modulation of PMN apoptosis by G-CSF and GM-CSF during the course of the acute respiratory distress syndrome (ARDS). Crit Care Med (in press)
60. Rubin DP, Wiener-Kronish JP, Murray JF, et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
61. Moss M, Ackerson L, Gillespie MK, et al. von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:15-20
62. McElroy MC, Pittet JF, Hashimoto S, et al. A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia. Am J Physiol 1995; 268:L181
63. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88:1976-1981
64. Wispe JR, Clark JC, Warner BB, et al. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990; 86:1954-1960
65. Dulkerian SJ, Gonzales LW, Ning Y, et al. Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol 1996; 15:781-786
66. Clark JG, Milberg JA, Steinberg KP, et al. Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995; 122:17-23
67. Chesnutt AN, Matthay MA, Tibayan FA, et al. Early detection of type III procollagen peptide in acute lung injury: pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997; 156:840-845
68. McHugh LG, Milberg JA, Whitcomb ME, et al. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:90-94
69. Madtes DK, Klima LD, Rubenfeld G, et al. Elevated transforming growth factor-α levels in bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158:424-430
70. Kheradmand F, Folkesson HG, Shum L, et al. Transforming growth factor-alpha enhances alveolar epithelial cell repair in a new in vitro model. Am J Physiol 1994; 267:L728-L738
71. Verghese GM, McCormick-Shannon K, Mason RJ, et al. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury: biological and clinical significance. Am J Respir Crit Care Med 1998; 158:386-394
72. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts outcome. Chest 1995; 108:1303-1314
73. Hudson LD, Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301